logo
Select company
Select metric
-0.63%Buyback Yield
VS
Market
29
Sector
57
Industry
70
History
85
$ 1.35Close
$ 1.06 - $ 2.55 52-Week Range
Ticker Information

Ticker

HRTX

Company Name

HERON THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

HERON THERAPEUTICS INC - Buyback Yield Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

HRTX - Buyback Yield Historical data
DateBuyback YieldMarket CapitalizationNet Cash Flow - Issuance (Purchase) of Equity Shares
6/30/2025-0.63%$ 202.35M$ 1.28M
3/31/2025-0.27%$ 369.2M$ 993K
12/31/2024-0.3%$ 312.28M$ 940K
9/30/2024-0.37%$ 194.68M$ 716K
6/30/2024-7.45%$ 404.95M$ 30.15M
3/31/2024-6.93%$ 432.37M$ 29.98M
12/31/2023-8.39%$ 354.78M$ 29.76M
9/30/2023-37.02%$ 81.04M$ 30M
6/30/2023-35.52%$ 212.55M$ 75.49M
3/31/2023-28.28%$ 266.96M$ 75.49M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • HERON THERAPEUTICS INC's latest trailing twelve months (TTM) Buyback Yield stands at -10.75%.
  • Over the past 5 years, HERON THERAPEUTICS INC's average Buyback Yield has been -9.86%.
  • The median Buyback Yield for HERON THERAPEUTICS INC during this period was -1.28%
  • HERON THERAPEUTICS INC reached its highest Buyback Yield over the past 5 years at -0.03%.
  • The lowest Buyback Yield recorded by HERON THERAPEUTICS INC in the same timeframe -37.24%

HERON THERAPEUTICS INC's Buyback Yield vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Buyback Yield Benchmarks
CompanyBuyback Yield
GLUE : MONTE ROSA THERAPEUTICS INC -0.38%CHRS : COHERUS ONCOLOGY INC -0.42%TRDA : ENTRADA THERAPEUTICS INC -0.92%MGNX : MACROGENICS INC -0.23%VNDA : VANDA PHARMACEUTICALS INC 0%AGEN : AGENUS INC -24.12%IGMS : IGM BIOSCIENCES INC -2.14%OSUR : ORASURE TECHNOLOGIES INC 2.44%ARCT : ARCTURUS THERAPEUTICS HOLDINGS INC -0.42%ALEC : ALECTOR INC -0.71%

Definition of Buyback Yield

[Calculation] The Buyback Yield is a ratio that calculates the difference between the trailing twelve-month share issuances and repurchases [NCFCommon] and divides it by the [MarketCap] of the company. A negative value indicates a dilution of shareholder value and might be considered as a warning sign.
(-1 * CF - Equity) / Market Cap
(=) Buyback Yield
Buyback Yield for HERON THERAPEUTICS INC is calculated as follows: (-1 * CF - Equity [ $ 168.47M ]) / Market Cap [ $ 1.57B ]
(=) Buyback Yield [ -10.75% ]

HRTX - Buyback Yield, Last 5 years

-37.24%

Minimum

Dec 31, 2022

-0.03%

Maximum

Jun 30, 2022

-9.86%

Average

-1.28%

Median

Buyback Yield Benchmark Analysis

The chart above depicts the distribution of Buyback Yield for companies in the Total Stock Market. The average Buyback Yield of the companies is 0.64% with a standard deviation of 2.71%.
The following table provides additional summary stats:
Buyback Yield in the Market:
filtered constituents3.28K
min-8.43%
max8.46%
average0.64%
median0.01%
std2.71%